Mongolian medicine in treating type 2 diabetes mellitus combined with nonalcoholic fatty liver disease via FXR/LXR-mediated P2X7R/NLRP3/NF-&#954;B pathway activation.

Bao, Shuyin; Wang, Xiuzhi; Ma, Qianqian; Wei, Chengxi; Nan, Jixing; Ao, Wuliji

Mongolian medicine in treating type 2 diabetes mellitus combined with nonalcoholic fatty liver disease via FXR/LXR-mediated P2X7R/NLRP3/NF-κB pathway activation.

Bao, Shuyin; Wang, Xiuzhi; Ma, Qianqian; Wei, Chengxi; Nan, Jixing; Ao, Wuliji.

Afiliação

Bao S; Institute of Pharmaceutical Chemistry and Pharmacology, Inner Mongolia Minzu University, Tongliao 028000, China.
Wang X; Inner Mongolia Key Laboratory of Mongolian Medicine Pharmacology for Cardio-Cerebral Vascular System, Tongliao 028000, China.
Ma Q; Jilin Key Laboratory for Traditional Chinese Korean Medicine, College of Pharmacy, Yanbian University, Yanji 133002, China.
Wei C; Department of Medicines and Foods, Tongliao Vocational College, Tongliao 028000, China.
Nan J; Institute of Pharmaceutical Chemistry and Pharmacology, Inner Mongolia Minzu University, Tongliao 028000, China.
Ao W; Inner Mongolia Key Laboratory of Mongolian Medicine Pharmacology for Cardio-Cerebral Vascular System, Tongliao 028000, China.

Chin Herb Med ; 14(3): 367-375, 2022 Jul.

Article em En | MEDLINE | ID: mdl-36118003

Palavras-chave

Mongolian medicine; Xike Rixijing Disease; nonalcoholic fatty liver disease; type 2 diabetes mellitus

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Chin Herb Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Chin Herb Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China